PULM
Pulmatrix, Inc.
Next earnings Aug 4, 2026
Last earnings -1.6% on 2026-05-15
$1.64
▼ -1.80%$1.64▼ -76.27%
over 1Y
L $1.19EODHDH $7.05
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-1.8%
1W+6.5%
1M+20.6%
3M+20.6%
YTD-27.4%
1Y-76.3%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Revenue grew 7.0% YoY; but unprofitable (net margin -66.1%).
Revenue (FY2024) $7.81M · FY2024
Pulmatrix, Inc. shows $7.81M in FY2024 revenue (+7.0% YoY), a -66.1% net margin, and -135.5% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $5.17M | $6.07M | $7.30M | $7.81M | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$20.2M | -$18.9M | -$14.7M | -$9.76M | -$5.17M |
| Net income | -$20.2M | -$18.8M | -$14.1M | -$9.56M | -$5.16M |
| Diluted EPS | — | -$5.46 | -$3.87 | -$2.62 | -$1.41 |
| Net margin | -390.2% | -310.3% | -193.5% | -122.5% | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$5.12M
EV / EBITDA—
EV / Sales0.7
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-86.2%
FCF yield-97.3%
Quality & risk
ROIC (est.)-58.1%
Free cash flow-$5.83M
Total debt$3.22M
Net cash$871K
Altman Z-Score-92.47 distress
Piotroski F-Score3/8
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.0%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRed flag in recent filings — restated periodic report (2026-06-16). Worth a closer look.
- 10-K/A Restated periodic report2026-06-16
- S-3 Shelf registration (potential raise)2026-06-04
- 8-K Earnings results2026-05-15
- 10-Q Quarterly report2026-05-15
- 8-K Reg FD disclosure2026-04-21
- 8-K Change in control2026-03-27
- 8-K Agreement terminated2026-03-02
- 8-K Earnings results2026-02-26
- 10-K Annual report2026-02-26
Recent filings
all on EDGAR ↗10-K/APeriod ending 2025-12-312026-06-16open ↗425Filing2026-06-05open ↗S-3Filing2026-06-04open ↗10-QPeriod ending 2026-03-312026-05-15open ↗8-KPeriod ending 2026-05-152026-05-15open ↗SCHEDULE 13DFiling2026-04-22open ↗8-KPeriod ending 2026-04-162026-04-21open ↗DFiling2026-04-15open ↗8-KPeriod ending 2026-03-262026-03-27open ↗425Filing2026-03-26open ↗8-KPeriod ending 2026-02-282026-03-02open ↗10-KPeriod ending 2025-12-312026-02-26open ↗
Frequently asked
- Is Pulmatrix, Inc. (PULM) a buy?
- PULM currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 7.0% YoY; but unprofitable (net margin -66.1%).
- What is Pulmatrix, Inc.'s quality score?
- PULM scores 63.11764705882353/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001574235, latest 10-Q filed 2026-05-15) · EODHD · as of 6/26/2026, 7:40:32 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.